Role of retinoic acid receptor in normal and leukemic bone marrow stromal cells
视黄酸受体在正常和白血病骨髓基质细胞中的作用
基本信息
- 批准号:05670929
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Retinoic acid (RA) exhibits effect on the proliferation and differentiation of many hematopoietic cells. Despite information on the effects of RA on hematopoietic cellslittle is known about how RA acts on the bone marrow stromal cells. All-trans RA and 9-cis RA,a stereoisomer of all-trans RA,treatment of humen bone marrow stromal cell line KM101, which produces M-CSF and GM-CSF constitutively, enhanced mRNA levels of both cytokines in a dose-dependent manner. Both RA also stimulated M-CSF production from primary human bone marrow stromal cells. All-trans RA did not affect the expression of RAR and RXR mRNA,whereas 9-cis RA increased RXR mRNA expression in a dose-dependent manner, suggesting RXR-dependentpathway through RAR/RXR or RXR/RXR must be critical in the cytokine production from bone marrow stromal cells. Next, we have developed several series of novel synthetic retinoids that selectively interact with RXR/RXR homodimers and RAR/RXR heterodimers. RXR-slective analogs had little ability to inhibit clonal growth and induce differentiation of leukemic cells. Howver, retinoid which activate both RAR/RXR and RXR/RXR dimers could inhibit clonal growth and induce differentiation of HL-60 cells as well as leukemic cells from patients with acute promyelocytic leukemia (APL). Thus, we conclude that the RAR/RXR pathway is more important than RXR/RXR pathway for differentiation and proliferation of acute myeloid leukemic cells.
维甲酸(RA)对多种造血细胞的增殖和分化有影响。尽管关于RA对造血细胞的影响的信息,但关于RA如何作用于骨髓基质细胞的信息知之甚少。全反式维甲酸和全反式维甲酸的立体异构体9-顺式维甲酸处理人骨髓基质细胞系KM 101(其组成性产生M-CSF和GM-CSF)后,以剂量依赖方式增强两种细胞因子的mRNA水平。这两种RA也刺激M-CSF的生产从原代人骨髓基质细胞。全反式RA不影响RAR和RXR mRNA的表达,而9-顺式RA以剂量依赖的方式增加RXR mRNA的表达,表明RAR/RXR或RXR/RXR的RXR依赖性途径在骨髓基质细胞产生细胞因子中起关键作用。接下来,我们开发了几个系列的新型合成类视色素,它们选择性地与RXR/RXR同源二聚体和RAR/RXR异源二聚体相互作用。RXR选择性类似物几乎没有抑制白血病细胞克隆生长和诱导分化的能力。同时激活RAR/RXR和RXR/RXR二聚体的维甲酸可抑制HL-60细胞的克隆生长并诱导其分化。因此,我们得出结论,RAR/RXR通路比RXR/RXR通路更重要的急性髓系白血病细胞的分化和增殖。
项目成果
期刊论文数量(66)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kizaki M,et al: "Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells." Blood. 83. 3289-3297 (1994)
Kizaki M 等人:“新型视黄酸,9-顺式视黄酸,与全反式视黄酸结合,是视黄酸抗性 HL-60 细胞分化的有效诱导剂。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakajima H,et al: "All-trans and 9-cis retinoic acid enhance 1, 25-dihydroxyvitamin D3 induced monocytic differentiation of U937 cells." Leuk Res,. (in press).
Nakajima H 等人:“全反式和 9-顺式视黄酸增强 1, 25-二羟基维生素 D3 诱导的 U937 细胞的单核细胞分化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kizaki,M.,et al: "Novel retinoic acid,9-cis retinoic acid,in combination with all-trans retinoic acid is effective inducer of differentiation of retinoic acid-resistant HL-60 cells" Blood. in press.
Kizaki,M.,等人:“新型视黄酸,9-顺式视黄酸,与全反式视黄酸组合是视黄酸抗性HL-60细胞分化的有效诱导剂”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kizaki M,et al: "Mechanisms of retinoid resistance : possible role of cytochrome P450 and P-glycoprotein." Blood. 87. 725-733 (1996)
Kizaki M 等人:“类视黄醇耐药机制:细胞色素 P450 和 P-糖蛋白的可能作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kizaki M, et al.: "Effects of novel retinoid X receptor (RXR) selective ligands on myeloid leukemic differentiation and proliferation in vitro" Blood. (in press).
Kizaki M 等人:“新型视黄醇 X 受体 (RXR) 选择性配体对体外骨髓白血病分化和增殖的影响”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIZAKI Masahiro其他文献
KIZAKI Masahiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIZAKI Masahiro', 18)}}的其他基金
Development of new therapeutic approach for multiple myeloma targeted against biological properties of bone marrow microenvironment
针对骨髓微环境的生物学特性开发多发性骨髓瘤新治疗方法
- 批准号:
24591409 - 财政年份:2012
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel molecular-targeting therapy for multiple myeloma against its progenitor cells
开发针对多发性骨髓瘤祖细胞的新型分子靶向疗法
- 批准号:
21591219 - 财政年份:2009
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of human leukemic stem cell by reactive oxygen species (ROS) and its therapeutic applications in the clinics
活性氧(ROS)对人白血病干细胞的调控及其临床治疗应用
- 批准号:
19591137 - 财政年份:2007
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of new molecular-targeted therapy for leukemia mediated through HIF-1 regulation by ROS
ROS介导的HIF-1调控白血病新分子靶向治疗的建立
- 批准号:
17591010 - 财政年份:2005
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of novel differentiation-inducing therapy for leukemia with hematopoietic growth factors and arsenic trioxide
造血生长因子和三氧化二砷新型白血病诱导分化疗法的建立
- 批准号:
13671083 - 财政年份:2001
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of apoptosis and differentiation induced by arsenic trioxide in leukemic cells and its clinical application
三氧化二砷诱导白血病细胞凋亡和分化的机制及其临床应用
- 批准号:
11671015 - 财政年份:1999
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of leukemic cell differentiation and apoptosis by retinoids.
类视黄醇白血病细胞分化和凋亡的分子机制。
- 批准号:
08671257 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Rethinking the retinoic acid receptor: a revisionary view of the rapid pathways triggered
重新思考视黄酸受体:对触发的快速途径的修正观点
- 批准号:
2281971 - 财政年份:2021
- 资助金额:
$ 1.34万 - 项目类别:
Studentship
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
- 批准号:
10019450 - 财政年份:2019
- 资助金额:
$ 1.34万 - 项目类别:
Involvement of retinoic acid receptor in COPD exacerbation
视黄酸受体参与 COPD 恶化
- 批准号:
19K17625 - 财政年份:2019
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
- 批准号:
9896234 - 财政年份:2019
- 资助金额:
$ 1.34万 - 项目类别:
Application of artificial intelligence-driven design of function-directed ligands for selective retinoic acid receptor binding
应用人工智能驱动的功能导向配体设计选择性视黄酸受体结合
- 批准号:
2281994 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Studentship
Elucidation of anti-obese mechanism via the retinoic acid receptor signal controlled by SMRT
通过 SMRT 控制的视黄酸受体信号阐明抗肥胖机制
- 批准号:
18K08486 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Application of artificial intelligence-driven design of function-directed ligands for selective retinoic acid receptor binding
应用人工智能驱动的功能导向配体设计选择性视黄酸受体结合
- 批准号:
BB/S507350/1 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Training Grant
NPIF Application of Artificial Intelligence-Driven Design of Function-Directed Ligands for Selective Retinoic Acid Receptor Binding
NPIF 应用人工智能驱动的功能导向配体设计进行选择性视黄酸受体结合
- 批准号:
2116078 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Studentship
Application of Artificial Intelligence-Driven Design of Function-Directed Ligands for Selective Retinoic Acid Receptor Binding
应用人工智能驱动的功能导向配体设计选择性视黄酸受体结合
- 批准号:
2104260 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Studentship
A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury
视黄酸受体β激动剂治疗脊髓损伤的一期试验
- 批准号:
MR/R006466/1 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Research Grant